Home Infusion Therapy Devices Market Global Report 2026

The home infusion therapy devices market size has grown rapidly in recent years. It will grow from $10.86 billion in 2025 to $12.03 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increasing demand for home healthcare, growth in the geriatric population, rising hospital discharge rates, and increasing need for long-term infusion therapies.

The home infusion therapy devices market size is expected to see rapid growth in the next few years. It will grow to $17.83 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. Growth during the forecast period is expected to be driven by the expansion of home-based healthcare services, increasing adoption of remote patient monitoring, growing demand for personalized drug delivery, rising healthcare expenditure, and the increasing shift toward decentralized care. Key trends during the forecast period include greater adoption of portable infusion devices, rising demand for ambulatory infusion pumps, increasing preference for disposable infusion devices, growing demand for home-based intravenous therapy, and greater emphasis on safe and precise drug delivery.

The expansion of telehealth and remote patient monitoring is expected to propel the growth of the home infusion therapy devices market going forward. Telehealth and remote patient monitoring refer to the use of digital technologies, connected devices, and virtual healthcare platforms to remotely monitor patients’ health conditions and deliver medical care. The adoption of telehealth and remote patient monitoring is increasing due to the growing need for convenient, cost-effective, and patient-centered healthcare solutions that minimize hospital visits and enable continuous disease management. Telehealth and remote patient monitoring facilitate the use of home infusion therapy devices by allowing healthcare providers to remotely monitor infusion progress, assess patient responses, and deliver timely interventions, thereby enhancing the safety, efficiency, and accessibility of home-based infusion treatments. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the expansion of telehealth and remote patient monitoring is driving the growth of the home infusion therapy devices market.

The growth of the aging population is expected to propel the growth of the home infusion therapy devices market going forward. The aging population refers to the rising proportion of elderly individuals within the overall population, who frequently require ongoing medical care and management of chronic conditions. The aging population is increasing due to longer life expectancy, as advancements in healthcare and medical treatments have enabled individuals to live longer, contributing to the expansion of the elderly population worldwide. Elderly individuals support the adoption of home infusion therapy devices by increasing the demand for convenient, cost-effective, and patient-friendly treatment options that allow them to receive intravenous therapies, including antibiotics, nutrition, and medications, in their homes. For instance, in November 2025, according to the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, the share of people aged 65 and over across OECD countries increased to 18.5% in 2023, while the number of individuals aged 65 and above surpassed 252 million in 2023, representing an increase of more than 10 million older adults within two years. Therefore, the growth of the aging population is driving the growth of the home infusion therapy devices market.

Major companies operating in the home infusion therapy devices market are concentrating on developing innovative solutions, such as connected ambulatory infusion platforms, to enhance remote patient monitoring, treatment accuracy, patient safety, and home-based care. Connected ambulatory infusion platforms are portable infusion systems that combine programmable drug delivery with wireless connectivity, enabling healthcare providers to remotely monitor infusion therapy, improve treatment management, and support better patient adherence compared with conventional standalone infusion pumps. For instance, in April 2023, Eitan Medical Ltd., an Israel-based medical device company, launched the Avoset Infusion Platform, an innovative connected multi-therapy ambulatory infusion system designed for post-acute care and specialty infusion therapy. The platform features compact, simplified technology with remote monitoring capabilities that enable clinicians to track infusion treatment data in real time, thereby enhancing patient safety and user experience. It is designed to support therapies requiring secure medication reservoirs, extended battery life, and low flow rates, while complementing the company’s Sapphire infusion portfolio. The MDR-certified system enables patients to receive infusion therapy safely and conveniently at home, supporting the growing shift toward connected, patient-centric home healthcare.

Major companies operating in the home infusion therapy devices market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Cardinal Health Inc., B. Braun SE, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Insulet Corporation, Teleflex Incorporated, F. Hoffmann-La Roche Ltd, Nipro Corporation, Moog Inc., Tandem Diabetes Care Inc., Avanos Medical Inc., InfuSystem Holdings Inc., Vygon SAS, Argon Medical Devices Inc., JMS Co. Ltd., Eitan Medical Ltd., SOOIL Development Co. Ltd., Micrel Medical Devices S.A., Ace Medical Co. Ltd.

Asia-Pacific was the dominating region in the home infusion therapy devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the home infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the home infusion therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.